Coya Therapeutics (COYA) Operating Margin (2023 - 2025)
Coya Therapeutics' Operating Margin history spans 3 years, with the latest figure at 68.26% for Q3 2025.
- For Q3 2025, Operating Margin changed N/A year-over-year to 68.26%; the TTM value through Sep 2025 reached 516.7%, down 39786.0%, while the annual FY2024 figure was 485.35%, 35368.0% down from the prior year.
- Operating Margin for Q3 2025 was 68.26% at Coya Therapeutics, up from 3920.47% in the prior quarter.
- Across five years, Operating Margin topped out at 30.24% in Q4 2023 and bottomed at 209031.51% in Q4 2024.
- The 3-year median for Operating Margin is 2976.89% (2025), against an average of 31483.46%.
- The largest annual shift saw Operating Margin crashed -20906175bps in 2024 before it surged 134595bps in 2025.
- A 3-year view of Operating Margin shows it stood at 30.24% in 2023, then crashed by -691308bps to 209031.51% in 2024, then surged by 100bps to 68.26% in 2025.
- Per Business Quant, the three most recent readings for COYA's Operating Margin are 68.26% (Q3 2025), 3920.47% (Q2 2025), and 2976.89% (Q1 2025).